Canadian biomanufacturing strategy launched to take advantage of $15 billion biopharmaceutical pipeline
CBI recommends $450 million investment over seven years to build capacity
08-Dec-2004 -
A $450-million investment is required over
the next seven years if Canada is to retain its leading position in the
rapidly growing biopharmaceutical industry and capitalize on the $15 billion
the country has already invested in the development of new, biologically based
drugs, the Centre for ...
biotechnology
clinical trials
clusters
+1